Bevacizumab in metastatic small-bowel adenocarcinoma: A systematic review and meta-analysis

Cancers of the small bowel could account for less than 5% of all gastrointestinal malignancies. Of these tumors, adenocarcinomas were the major histologic subtype and generally carried a poor prognosis. High expression of vascular epithelial growth factor (VEGF) could be seen in small bowel adenocar...

Descripción completa

Detalles Bibliográficos
Autores principales: Vergara, John Paulo, Sacdalan, Danielle Benedict Leoncio, Amurao-Amante, Madelaine, Sacdalan, Dennis Lee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832313/
https://www.ncbi.nlm.nih.gov/pubmed/35154612
http://dx.doi.org/10.1177/2036361318825413

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832313/
https://www.ncbi.nlm.nih.gov/pubmed/35154612
http://dx.doi.org/10.1177/2036361318825413

Ejemplares similares